Adverse Events Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module

Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2025-12-25 @ 7:00 PM
NCT ID: NCT01642004
Description: All-Cause Mortality = all randomized participants. Serious Adverse Events and Other Adverse Events = all treated participants. ARM 1: AEs that occurred on 3mg/kg Nivolumab, ARM 2: AEs that occurred on 480 mg Nivolumab, ARM 3: AEs that occurred on Docetaxel treatment only, ARM 4: Extension phase of Docetaxel arm: AEs that occurred on 3mg/kg Nivolumab, ARM 5: Extension phase of Docetaxel arm: AEs that occurred on or 480 mg Nivolumab
Frequency Threshold: 5
Time Frame: Participants were assessed for all-cause mortality from their enrollment to study completion, (up to approximately 103 months). SAEs and Other AEs were assessed from first dose to 100 days following last dose (up to approximately 94 months).
Study: NCT01642004
Study Brief: Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Nivolumab 3 mg/kg Nivolumab 3 mg/kg solution intravenously every 2 weeks until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends. 119 None 85 131 120 131 View
Nivolumab 480 mg Nivolumab 480 mg solution intravenously every 4 weeks until documented disease progression, discontinuation due to toxicity, withdrawal of consent or the study ends. 2 None 1 6 4 6 View
Docetaxel Docetaxel 75mg/m\^2 solution intravenously every 3 weeks until documented disease progression , discontinuation due to toxicity, withdrawal of consent or study ends. 129 None 92 129 123 129 View
Extension Phase of Docetaxel Arm: Nivolumab 3 mg/kg Eligible patients from the Docetaxel arm may receive nivolumab 3 mg/kg every 2 weeks via extension phase until documented disease progression, discontinuation due to toxicity, withdrawal of consent or study ends. 5 None 4 6 4 6 View
Extension Phase of Docetaxel Arm: Nivolumab 480 mg Eligible patients from the Docetaxel arm may receive nivolumab 480 mg flat dose every 4 weeks via extension phase until documented disease progression, discontinuation due to toxicity, withdrawal of consent or study ends. 1 None 0 1 1 1 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Febrile bone marrow aplasia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Febrile neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Myelosuppression SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Pancytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Atrial fibrillation SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Atrial flutter SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Atrial thrombosis SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Cardiac failure SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Cardiac tamponade SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Sepsis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Septic shock SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Skin infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Hypercalcaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hyperglycaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hypoglycaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hypokalaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hypomagnesaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hyponatraemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hypophosphataemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Musculoskeletal pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Neck pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Basal cell carcinoma SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Gastric cancer SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Lung neoplasm malignant SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Malignant neoplasm progression SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Metastases to central nervous system SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Squamous cell carcinoma SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Tumour pain SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Aphasia SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Cerebrovascular accident SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Facial paralysis SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Generalised tonic-clonic seizure SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Ischaemic stroke SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Myasthenic syndrome SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Peripheral sensory neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Seizure SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Spinal cord compression SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Syncope SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Confusional state SYSTEMATIC_ASSESSMENT Psychiatric disorders 24.0 View
Delirium SYSTEMATIC_ASSESSMENT Psychiatric disorders 24.0 View
Mental status changes SYSTEMATIC_ASSESSMENT Psychiatric disorders 24.0 View
Haematuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders 24.0 View
Tubulointerstitial nephritis SYSTEMATIC_ASSESSMENT Renal and urinary disorders 24.0 View
Ureterolithiasis SYSTEMATIC_ASSESSMENT Renal and urinary disorders 24.0 View
Acute respiratory failure SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Bronchial obstruction SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Chronic obstructive pulmonary disease SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Haemoptysis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Interstitial lung disease SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Oropharyngeal pain SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pleural effusion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pneumonitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pneumothorax SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pulmonary embolism SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pulmonary haemorrhage SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pulmonary thrombosis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Respiratory distress SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Respiratory failure SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Stridor SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Aortic aneurysm rupture SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Arterial haemorrhage SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Peripheral ischaemia SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Superior vena cava syndrome SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Viral infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Fall SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications 24.0 View
Radiation oesophagitis SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications 24.0 View
Blood potassium decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
C-reactive protein increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Electrocardiogram abnormal SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Failure to thrive SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Cardio-respiratory arrest SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Myocardial infarction SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Pericardial effusion SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Sinus bradycardia SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Adrenal insufficiency SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Goitre SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Hypothyroidism SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Dysphagia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Intestinal perforation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Oesophagitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Oesophagitis ulcerative SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Pancreatitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Pneumoperitoneum SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Asthenia SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Chills SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders 24.0 View
General physical health deterioration SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Multiple organ dysfunction syndrome SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Oedema peripheral SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Pain SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Sudden death SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Swelling SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Immune-mediated hepatitis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Bacterial infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Clostridium difficile colitis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Enterocolitis infectious SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Lower respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Neutropenic infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Pneumocystis jirovecii pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Leukopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Hypothyroidism SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Asthenia SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Chest pain SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Chills SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Mucosal inflammation SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Non-cardiac chest pain SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Oedema peripheral SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Pain SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Blood alkaline phosphatase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Neutrophil count decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Weight decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
White blood cell count decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hypercalcaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hyperglycaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hypokalaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hypomagnesaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Bone pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Musculoskeletal chest pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Neuropathy peripheral SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Paraesthesia SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders 24.0 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Dysphonia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Haemoptysis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Productive cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Alopecia SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Pruritus SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Adrenal insufficiency SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Cushing's syndrome SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Blepharochalasis SYSTEMATIC_ASSESSMENT Eye disorders 24.0 View
Trichiasis SYSTEMATIC_ASSESSMENT Eye disorders 24.0 View
Anal ulcer SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Dry mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Epigastric discomfort SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Glossodynia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Haemorrhoids SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Oesophageal compression SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Toothache SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Generalised oedema SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Sensation of foreign body SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Oral candidiasis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Paronychia SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Pustule SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Respiratory tract infection viral SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Traumatic haematoma SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications 24.0 View
Vascular access site haematoma SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications 24.0 View
Alanine aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Aspartate aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Blood creatinine increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Gout SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hyponatraemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Vitamin D deficiency SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Arthritis SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Muscle spasms SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Neck pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Pneumonitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Sputum discoloured SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Dry skin SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Erythema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Pain of skin SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Rash erythematous SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Rash macular SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Xanthelasma SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Hot flush SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Hypertensive heart disease SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Visual impairment SYSTEMATIC_ASSESSMENT Eye disorders 24.0 View
Malaise SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Parkinson's disease SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Benign prostatic hyperplasia SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders 24.0 View